FDA approval extends nivolumab into first-line stage III/IV cHL in adults and pediatrics, following priority review of the supplemental application for nivolumab plus AVD. SWOG S1826 showed superior ...

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

American Vanguard Corp. (AVD) on Monday reported a loss of $28.2 million in its fourth quarter. On a per-share basis, the Newport ...

American Vanguard (AVD) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook ...

The 3-year PFS rates were 91% for the N-AVD group and 82% for the BV-AVD group. For patients with advanced-stage classic Hodgkin lymphoma (cHL), an updated analysis of the S1826 study showed a ...

Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q4 2025 investor letter. A copy of the letter can be downloaded here. Both Q4 and the full year 2025 ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Reduction in GA lesion progression at 3 months was ...

When it comes to Android virtual devices there are many options available, including installing Android on VirtualBox. But when it comes to testing apps and debugging, two names are thrown around ...